Product Images Victoza

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 22 images provide visual information about the product associated with Victoza NDC 50090-2853 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Structural Formula of liraglutide - 49f302f5 f315 48b8 83a4 6ca56f01fded 01

Figure 1: Structural Formula of liraglutide - 49f302f5 f315 48b8 83a4 6ca56f01fded 01

Figure 2 Mean Insulin Secretion Rate (ISR) versus Glucose Concentration - 49f302f5 f315 48b8 83a4 6ca56f01fded 02

Figure 2 Mean Insulin Secretion Rate (ISR) versus Glucose Concentration - 49f302f5 f315 48b8 83a4 6ca56f01fded 02

This is a graph showing the effect of 15K pmol/kg/min dose of Victoza compared to Placebo on plasma glucose levels (mg/dL). Any additional information or context is not available from the given text.*

Figure 4 Mean HbA1c for patients who completed the 26-week trial and for the Last Observation Carried Forward (LOCF, intent-to-treat) data at Week 26 - 49f302f5 f315 48b8 83a4 6ca56f01fded 04

Figure 4 Mean HbA1c for patients who completed the 26-week trial and for the Last Observation Carried Forward (LOCF, intent-to-treat) data at Week 26 - 49f302f5 f315 48b8 83a4 6ca56f01fded 04

Victoza Pen and Needle - image 01

Victoza Pen and Needle - image 01

The text is describing the components of a Victoza® Pen used for insulin injections. It includes details about the rubber cartridge tip, the dose control, the display pointer, and the needle. In case of any issues, the user is instructed to call the toll-free number or visit the website provided.*

Fig. A - Pull off pen cap - image 02

Fig. A - Pull off pen cap - image 02

Fig. B - Remove protective tab. - image 03

Fig. B - Remove protective tab. - image 03

Fig. C and D - - image 04

Fig. C and D - - image 04

Fig. E - image 05

Fig. E - image 05

Fig. F - image 06

Fig. F - image 06

Fig. G - image 07

Fig. G - image 07

Fig. H - Pull off pen cap. - image 08

Fig. H - Pull off pen cap. - image 08

Fig. I - image 09

Fig. I - image 09

Fig. J-K - image 10

Fig. J-K - image 10

Fig. L - image 11

Fig. L - image 11

Fig. M - image 12

Fig. M - image 12

Fig. N - image 13

Fig. N - image 13

Fig. O - image 14

Fig. O - image 14

Fig. P - image 15

Fig. P - image 15

Fig. Q - image 16

Fig. Q - image 16

Figure 5 - image 20

Figure 5 - image 20

This appears to be a graph or chart depicting the effectiveness of a drug called Victoza compared to a placebo. The x-axis measures time from randomization in months, and the y-axis measures the number of patients at risk. The chart displays data up to 54 months, with patients at risk decreasing over time. The HR (hazard ratio) for Victoza is given as 0.87 with a 95% confidence interval. The text indicates this is the full analysis set.*

Figure 3 - image 21

Figure 3 - image 21

Label Image - lbl500902853

Label Image - lbl500902853

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.